EYECARE OcuTerra Appoints Richard Lindstrom, MD, and Sheri Rowen, MD, to Scientific Advisory Board By Staff Wednesday, July 14, 2021 12:15 AM BOSTON—OcuTerra Therapeutics, a clinical stage ophthalmology company, announced the appointments of Richard Lindstrom, MD, and Sheri Rowen, MD, to its scientific advisory board. “True visionaries, Dick and Sheri are renowned for the advancements and contributions they have made to the field of vision. We are thrilled they are joining our Scientific Advisory Board at this pivotal time of growth at OcuTerra,” said Kerrie Brady, chief executive officer of OcuTerra. “The breadth of their expertise as ophthalmologists and commitment to innovation aligns with our mission to change the standard of care for the treatment of diabetic eye disease.”Dr. Lindstrom and Dr. Rowen join an esteemed group of scientific advisors at OcuTerra, where they will serve as “a strategic resource and provide scientific review and counsel to help guide the company’s development of innovative drugs for ophthalmic diseases for which the current standard of care of watch and wait does not prevent or control the progression of disease,” the company said.Dr. Lindstrom is a founder and attending surgeon at Minnesota Eye Consultants, P.A., a provider of eyecare services. A board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive and laser surgery, Dr. Lindstrom has developed a number of solutions, intraocular lenses and instruments that are used in clinical practices globally.Dr. Lindstrom is adjunct clinical professor emeritus at the University of Minnesota, Department of Ophthalmology. He is board member, University of Minnesota Foundation and visiting professor, UC Irvine‘s Gavin Herbert Eye Institute. He also is past president of the American Society of Cataract and Refractive Surgeons and the International Society of Refractive Surgery.Dr. Rowen is an experienced physician who has pioneered new treatments and techniques for ophthalmic surgery. She is active in helping pave the way for new ophthalmic innovations coming to market by serving as Principal Investigator for numerous FDA trials. Dr. Rowen is an advisor on several medical and scientific advisory boards and continues to practice in Newport Beach, Calif. Dr. Rowen is certified by the American Board of Ophthalmology and is a fellow of the American Academy of Ophthalmology and the American College of Surgeons. She is also an active member of the American Society of Cataract and Refractive Surgeons. Dr. Rowen acts as president emeritus of Cedars Aspens Society and serves on the medical editorial board of CRST and Presbyopia Physician.